BeStock  
Stocks › Biotechnology › ADMA

ADMA Biologics ADMA

US equityMarket cap rank #2693Biotechnology
$10.11 +$0.39 (+4.01%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $10.20 +0.89%
Open$9.63
Prev close$9.72
Day range$9.62 – $10.19
Volume3.51M
Market cap$2.26B
P/E (TTM)14.4
Dividend yield–

ADMA Stock News

Headlines matching ADMA Biologics or the ADMA ticker, most recent first.

  • CCORF Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $18Market news · 6 Aug 2026
  • Cantor Fitzgerald Maintains ADMA Biologics(ADMA.US) With Hold Rating, Cuts Target Price to $12Market news · 6 Aug 2026
  • ADMA Biologics Q2 Adj. EPS $0.16 Misses $0.17 Estimate, Sales $124.395M Miss $131.658M EstimateBenzinga · 6 Aug 2026
  • 4: ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Kestenberg-Messina Kaitlin M.SEC · 29 Jul 2026
  • Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $17Market news · 15 Jul 2026
  • Raymond James Initiates ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $21Market news · 10 Jun 2026
  • Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $20Market news · 7 May 2026
  • CCORF Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $21Market news · 5 May 2026
  • ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Kestenberg-Messina Kaitlin M.SEC · 4 Apr 2026
  • Raymond James Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $21Market news · 21 Apr 2026
  • Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $24Market news · 14 Apr 2026
  • Cantor Fitzgerald Downgrades ADMA Biologics(ADMA.US) to Hold Rating, Maintains Target Price $30Market news · 26 Mar 2026
  • ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Director Guiheen Lawrence P.SEC · 18 Mar 2026
  • ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Kestenberg-Messina Kaitlin M.SEC · 11 Mar 2026
  • Cantor Fitzgerald Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $30Market news · 26 Feb 2026

Discussion

No comments yet — be the first to weigh in on ADMA.

Leave a comment

Scroll to Top